Max Seibold
Concepts (431)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 56 | 2025 | 1918 | 6.570 |
Why?
| | Respiratory Mucosa | 15 | 2025 | 325 | 3.790 |
Why?
| | Interleukin-13 | 11 | 2024 | 149 | 2.980 |
Why?
| | Transcriptome | 11 | 2025 | 1029 | 2.600 |
Why?
| | Mucin 5AC | 6 | 2024 | 69 | 2.190 |
Why?
| | Nasal Mucosa | 8 | 2024 | 111 | 1.990 |
Why?
| | Gene Expression Profiling | 16 | 2020 | 1794 | 1.880 |
Why?
| | Epithelial Cells | 14 | 2024 | 1125 | 1.870 |
Why?
| | Adrenal Cortex Hormones | 9 | 2025 | 505 | 1.610 |
Why?
| | Virus Diseases | 2 | 2025 | 218 | 1.520 |
Why?
| | Hypersensitivity | 5 | 2024 | 258 | 1.430 |
Why?
| | Mucus | 4 | 2025 | 79 | 1.370 |
Why?
| | Lectins | 2 | 2024 | 43 | 1.310 |
Why?
| | Respiratory Tract Infections | 4 | 2025 | 389 | 1.250 |
Why?
| | Bronchodilator Agents | 7 | 2025 | 196 | 0.990 |
Why?
| | Lung | 14 | 2026 | 4101 | 0.990 |
Why?
| | Common Cold | 1 | 2025 | 15 | 0.950 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2022 | 2177 | 0.950 |
Why?
| | Mucin-5B | 5 | 2020 | 227 | 0.920 |
Why?
| | Genetic Predisposition to Disease | 14 | 2019 | 2417 | 0.890 |
Why?
| | Th2 Cells | 6 | 2023 | 180 | 0.880 |
Why?
| | Particulate Matter | 3 | 2025 | 342 | 0.850 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 78 | 0.830 |
Why?
| | Inhalation Exposure | 1 | 2025 | 116 | 0.830 |
Why?
| | Environmental Exposure | 4 | 2025 | 588 | 0.830 |
Why?
| | Picornaviridae Infections | 5 | 2025 | 51 | 0.820 |
Why?
| | Epithelium | 3 | 2023 | 314 | 0.810 |
Why?
| | Alveolar Epithelial Cells | 3 | 2026 | 121 | 0.810 |
Why?
| | Idiopathic Pulmonary Fibrosis | 6 | 2026 | 674 | 0.800 |
Why?
| | Viruses | 1 | 2025 | 164 | 0.790 |
Why?
| | Hexosaminidases | 2 | 2016 | 15 | 0.770 |
Why?
| | Air Pollutants | 3 | 2025 | 442 | 0.760 |
Why?
| | Air Pollution, Indoor | 1 | 2025 | 183 | 0.760 |
Why?
| | Interferons | 2 | 2020 | 195 | 0.740 |
Why?
| | Environmental Monitoring | 1 | 2025 | 374 | 0.730 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 55 | 0.700 |
Why?
| | Single-Cell Analysis | 4 | 2021 | 354 | 0.700 |
Why?
| | Severity of Illness Index | 6 | 2025 | 2936 | 0.690 |
Why?
| | Rhinovirus | 5 | 2025 | 58 | 0.690 |
Why?
| | Sequence Analysis, RNA | 8 | 2021 | 447 | 0.690 |
Why?
| | Humans | 91 | 2026 | 143560 | 0.680 |
Why?
| | Child | 34 | 2025 | 22725 | 0.680 |
Why?
| | Trachea | 2 | 2020 | 250 | 0.650 |
Why?
| | Enterovirus Infections | 2 | 2023 | 174 | 0.650 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2018 | 549 | 0.630 |
Why?
| | Serine Endopeptidases | 1 | 2020 | 130 | 0.620 |
Why?
| | Gene Expression Regulation | 9 | 2023 | 2621 | 0.610 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 368 | 0.600 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 378 | 0.570 |
Why?
| | Coronavirus Infections | 2 | 2020 | 373 | 0.570 |
Why?
| | Betacoronavirus | 2 | 2020 | 280 | 0.570 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 3 | 2019 | 25 | 0.560 |
Why?
| | Case-Control Studies | 14 | 2025 | 3625 | 0.560 |
Why?
| | Dermatitis, Atopic | 5 | 2019 | 333 | 0.560 |
Why?
| | STAT6 Transcription Factor | 1 | 2018 | 27 | 0.560 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2018 | 56 | 0.550 |
Why?
| | Smoking | 2 | 2020 | 1580 | 0.550 |
Why?
| | Genome, Human | 2 | 2018 | 429 | 0.540 |
Why?
| | Host-Pathogen Interactions | 2 | 2020 | 369 | 0.540 |
Why?
| | Pyridines | 2 | 2025 | 593 | 0.540 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1051 | 0.540 |
Why?
| | Stem Cells | 2 | 2026 | 619 | 0.530 |
Why?
| | Cadherins | 1 | 2019 | 202 | 0.530 |
Why?
| | Sputum | 7 | 2025 | 313 | 0.510 |
Why?
| | RNA Virus Infections | 1 | 2017 | 20 | 0.510 |
Why?
| | Gene Editing | 1 | 2018 | 89 | 0.510 |
Why?
| | Male | 50 | 2026 | 71500 | 0.500 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 162 | 0.490 |
Why?
| | Gene Deletion | 1 | 2018 | 394 | 0.490 |
Why?
| | Amides | 1 | 2016 | 97 | 0.480 |
Why?
| | Female | 50 | 2026 | 77251 | 0.470 |
Why?
| | Adipokines | 1 | 2016 | 53 | 0.470 |
Why?
| | RNA Viruses | 1 | 2017 | 76 | 0.470 |
Why?
| | Child, Preschool | 14 | 2025 | 11737 | 0.450 |
Why?
| | Adolescent | 27 | 2025 | 22481 | 0.450 |
Why?
| | Steroids | 1 | 2016 | 165 | 0.450 |
Why?
| | Inflammation | 8 | 2025 | 2881 | 0.440 |
Why?
| | Puerto Rico | 6 | 2025 | 54 | 0.440 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2025 | 359 | 0.440 |
Why?
| | Genome-Wide Association Study | 8 | 2023 | 1452 | 0.430 |
Why?
| | Forced Expiratory Volume | 5 | 2020 | 485 | 0.420 |
Why?
| | Polymorphism, Genetic | 4 | 2024 | 626 | 0.420 |
Why?
| | Airway Remodeling | 3 | 2025 | 71 | 0.420 |
Why?
| | Pulmonary Fibrosis | 2 | 2023 | 392 | 0.400 |
Why?
| | Membrane Proteins | 2 | 2020 | 1171 | 0.400 |
Why?
| | Cytokines | 6 | 2025 | 2097 | 0.400 |
Why?
| | Chitinases | 2 | 2009 | 9 | 0.380 |
Why?
| | Haplotypes | 3 | 2011 | 496 | 0.360 |
Why?
| | Gene Expression | 7 | 2023 | 1505 | 0.360 |
Why?
| | Adult | 30 | 2025 | 40013 | 0.350 |
Why?
| | Bronchi | 5 | 2020 | 267 | 0.350 |
Why?
| | Metaplasia | 2 | 2022 | 58 | 0.350 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 60 | 0.340 |
Why?
| | Animals | 24 | 2026 | 38010 | 0.340 |
Why?
| | Lung Diseases | 1 | 2018 | 787 | 0.340 |
Why?
| | Air Pollution | 3 | 2020 | 330 | 0.340 |
Why?
| | Mice | 18 | 2026 | 18378 | 0.330 |
Why?
| | Middle Aged | 21 | 2025 | 35342 | 0.330 |
Why?
| | Cells, Cultured | 7 | 2020 | 4182 | 0.320 |
Why?
| | Allergens | 4 | 2021 | 408 | 0.320 |
Why?
| | Mexican Americans | 3 | 2022 | 114 | 0.320 |
Why?
| | Disease Progression | 5 | 2025 | 2856 | 0.310 |
Why?
| | Genomics | 4 | 2024 | 831 | 0.300 |
Why?
| | Gene-Environment Interaction | 3 | 2020 | 191 | 0.290 |
Why?
| | Genotype | 8 | 2019 | 1877 | 0.290 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 8 | 0.280 |
Why?
| | Cystic Fibrosis | 3 | 2025 | 1142 | 0.280 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 150 | 0.280 |
Why?
| | Urban Population | 3 | 2024 | 491 | 0.280 |
Why?
| | Cell Differentiation | 6 | 2018 | 2020 | 0.280 |
Why?
| | Prospective Studies | 7 | 2025 | 7899 | 0.280 |
Why?
| | Linkage Disequilibrium | 6 | 2020 | 254 | 0.270 |
Why?
| | Fibroblasts | 3 | 2026 | 1044 | 0.270 |
Why?
| | Cellular Reprogramming | 2 | 2020 | 103 | 0.270 |
Why?
| | Young Adult | 16 | 2025 | 13972 | 0.260 |
Why?
| | Cohort Studies | 5 | 2025 | 5891 | 0.260 |
Why?
| | Minority Groups | 3 | 2022 | 279 | 0.250 |
Why?
| | DNA Methylation | 3 | 2023 | 667 | 0.250 |
Why?
| | Interleukin-33 | 2 | 2016 | 50 | 0.240 |
Why?
| | Genetic Variation | 4 | 2020 | 1008 | 0.240 |
Why?
| | Enterovirus | 3 | 2024 | 85 | 0.240 |
Why?
| | Cilia | 2 | 2020 | 173 | 0.230 |
Why?
| | Oscillometry | 1 | 2025 | 36 | 0.230 |
Why?
| | Regeneration | 2 | 2026 | 198 | 0.230 |
Why?
| | Basement Membrane | 1 | 2025 | 32 | 0.230 |
Why?
| | tau Proteins | 1 | 2026 | 98 | 0.220 |
Why?
| | Rhinitis, Allergic | 1 | 2025 | 44 | 0.220 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2024 | 29 | 0.220 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2026 | 245 | 0.220 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 375 | 0.220 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 658 | 0.210 |
Why?
| | Immunity, Innate | 2 | 2021 | 861 | 0.210 |
Why?
| | Transcription Factors | 4 | 2023 | 1754 | 0.210 |
Why?
| | Albuterol | 3 | 2023 | 75 | 0.210 |
Why?
| | Genetic Association Studies | 2 | 2016 | 377 | 0.210 |
Why?
| | Risk Factors | 7 | 2025 | 10644 | 0.210 |
Why?
| | Benzodioxoles | 1 | 2025 | 144 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 135 | 0.210 |
Why?
| | Skin | 2 | 2019 | 774 | 0.200 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 266 | 0.200 |
Why?
| | Treatment Outcome | 6 | 2025 | 11365 | 0.200 |
Why?
| | Pandemics | 3 | 2021 | 1668 | 0.200 |
Why?
| | Viral Load | 1 | 2025 | 514 | 0.200 |
Why?
| | Helminthiasis | 1 | 2023 | 11 | 0.200 |
Why?
| | Quinolones | 1 | 2025 | 180 | 0.200 |
Why?
| | Aminophenols | 1 | 2025 | 181 | 0.200 |
Why?
| | Microtubules | 1 | 2026 | 284 | 0.200 |
Why?
| | Chemokine CCL5 | 1 | 2023 | 43 | 0.200 |
Why?
| | Pulmonary Alveoli | 1 | 2026 | 392 | 0.200 |
Why?
| | Family Characteristics | 1 | 2024 | 192 | 0.190 |
Why?
| | Nasal Polyps | 1 | 2023 | 62 | 0.190 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 103 | 0.180 |
Why?
| | Salmeterol Xinafoate | 1 | 2021 | 22 | 0.180 |
Why?
| | Indoles | 1 | 2025 | 479 | 0.180 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 686 | 0.180 |
Why?
| | Fluticasone | 1 | 2021 | 56 | 0.180 |
Why?
| | Sulfonamides | 1 | 2026 | 582 | 0.180 |
Why?
| | Signal Transduction | 6 | 2026 | 5214 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2026 | 539 | 0.180 |
Why?
| | Surgical Tape | 2 | 2019 | 5 | 0.180 |
Why?
| | Anti-Asthmatic Agents | 1 | 2024 | 273 | 0.180 |
Why?
| | Macrophages, Alveolar | 2 | 2019 | 373 | 0.180 |
Why?
| | Strongylida Infections | 1 | 2021 | 8 | 0.180 |
Why?
| | Down-Regulation | 2 | 2021 | 644 | 0.170 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 60 | 0.170 |
Why?
| | Rhinitis | 1 | 2023 | 173 | 0.170 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2020 | 29 | 0.170 |
Why?
| | Gene Frequency | 3 | 2011 | 492 | 0.170 |
Why?
| | Interleukin-4 | 2 | 2020 | 216 | 0.170 |
Why?
| | Respiratory Function Tests | 4 | 2025 | 560 | 0.170 |
Why?
| | Epidermis | 2 | 2019 | 159 | 0.160 |
Why?
| | Gene Regulatory Networks | 2 | 2020 | 319 | 0.160 |
Why?
| | fas Receptor | 1 | 2020 | 94 | 0.160 |
Why?
| | Virus Internalization | 1 | 2020 | 64 | 0.160 |
Why?
| | Administration, Inhalation | 5 | 2025 | 597 | 0.160 |
Why?
| | Stem Cell Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 77 | 0.160 |
Why?
| | Keratinocytes | 2 | 2018 | 253 | 0.160 |
Why?
| | Biomarkers | 4 | 2022 | 4241 | 0.160 |
Why?
| | Sinusitis | 1 | 2023 | 239 | 0.160 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 117 | 0.160 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.150 |
Why?
| | Neutrophils | 3 | 2023 | 1134 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 124 | 0.150 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 12 | 0.150 |
Why?
| | Smokers | 1 | 2020 | 146 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 347 | 0.150 |
Why?
| | Biological Transport | 1 | 2020 | 412 | 0.150 |
Why?
| | Eczema | 1 | 2019 | 69 | 0.150 |
Why?
| | CD11c Antigen | 1 | 2019 | 40 | 0.150 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2020 | 136 | 0.150 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2019 | 37 | 0.150 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2018 | 8 | 0.150 |
Why?
| | Lymphocytes | 1 | 2021 | 398 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2021 | 365 | 0.140 |
Why?
| | Clone Cells | 2 | 2016 | 270 | 0.140 |
Why?
| | Cell Line | 5 | 2020 | 2897 | 0.140 |
Why?
| | Smad2 Protein | 1 | 2018 | 38 | 0.140 |
Why?
| | Pharmacogenetics | 2 | 2010 | 167 | 0.140 |
Why?
| | Receptors, Odorant | 1 | 2018 | 32 | 0.140 |
Why?
| | Dendritic Cells | 2 | 2019 | 502 | 0.140 |
Why?
| | Pharmacogenomic Variants | 1 | 2018 | 32 | 0.140 |
Why?
| | Acetyltransferases | 1 | 2018 | 21 | 0.140 |
Why?
| | Infant | 5 | 2025 | 9981 | 0.140 |
Why?
| | Spirometry | 3 | 2025 | 263 | 0.130 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 101 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2580 | 0.130 |
Why?
| | Eosinophilia | 1 | 2020 | 225 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2018 | 823 | 0.130 |
Why?
| | Glycoproteins | 1 | 2019 | 356 | 0.130 |
Why?
| | Epigenomics | 2 | 2023 | 115 | 0.130 |
Why?
| | Cell-Matrix Junctions | 1 | 2016 | 2 | 0.130 |
Why?
| | Phosphoproteins | 1 | 2019 | 337 | 0.130 |
Why?
| | Aged | 8 | 2025 | 25322 | 0.120 |
Why?
| | Cockroaches | 1 | 2016 | 22 | 0.120 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2017 | 100 | 0.120 |
Why?
| | Nose | 1 | 2016 | 65 | 0.120 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2016 | 89 | 0.120 |
Why?
| | Disease Susceptibility | 2 | 2025 | 354 | 0.120 |
Why?
| | Culture Media | 1 | 2016 | 165 | 0.120 |
Why?
| | Bronchiolitis, Viral | 1 | 2015 | 11 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1064 | 0.120 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 189 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 471 | 0.120 |
Why?
| | Emergency Service, Hospital | 2 | 2025 | 2270 | 0.120 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 377 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2015 | 34 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 636 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2021 | 1130 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2025 | 6366 | 0.110 |
Why?
| | Genetic Testing | 1 | 2018 | 474 | 0.110 |
Why?
| | Mice, Knockout | 4 | 2026 | 3109 | 0.110 |
Why?
| | Cell Communication | 1 | 2016 | 313 | 0.110 |
Why?
| | Pulmonary Emphysema | 1 | 2017 | 310 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 523 | 0.110 |
Why?
| | Indians, North American | 1 | 2020 | 661 | 0.110 |
Why?
| | Up-Regulation | 2 | 2018 | 863 | 0.110 |
Why?
| | Lipid Metabolism | 1 | 2018 | 524 | 0.110 |
Why?
| | Alternative Splicing | 1 | 2016 | 243 | 0.110 |
Why?
| | Eosinophils | 3 | 2023 | 325 | 0.100 |
Why?
| | United States | 10 | 2024 | 15553 | 0.100 |
Why?
| | Mice, Inbred C57BL | 5 | 2026 | 6043 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2014 | 117 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4522 | 0.100 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2012 | 12 | 0.100 |
Why?
| | Computational Biology | 1 | 2018 | 677 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2021 | 639 | 0.090 |
Why?
| | Exons | 1 | 2014 | 359 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2019 | 825 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 928 | 0.090 |
Why?
| | Software | 1 | 2018 | 687 | 0.090 |
Why?
| | Cysts | 1 | 2013 | 114 | 0.090 |
Why?
| | Dinoprostone | 2 | 2023 | 182 | 0.090 |
Why?
| | Extracellular Matrix | 1 | 2016 | 558 | 0.090 |
Why?
| | Anaphylaxis | 1 | 2013 | 104 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2019 | 637 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1369 | 0.090 |
Why?
| | Peanut Hypersensitivity | 1 | 2013 | 146 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 420 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 517 | 0.090 |
Why?
| | Beclomethasone | 1 | 2010 | 9 | 0.080 |
Why?
| | Phenotype | 3 | 2014 | 3211 | 0.080 |
Why?
| | Lipids | 3 | 2023 | 704 | 0.080 |
Why?
| | Precision Medicine | 1 | 2015 | 444 | 0.080 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 24 | 0.080 |
Why?
| | Genetic Linkage | 1 | 2011 | 288 | 0.080 |
Why?
| | Intestines | 1 | 2013 | 356 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2019 | 2026 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 273 | 0.080 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1263 | 0.080 |
Why?
| | Mast Cells | 2 | 2025 | 151 | 0.080 |
Why?
| | Antigens, Bacterial | 1 | 2010 | 126 | 0.080 |
Why?
| | Alleles | 3 | 2019 | 893 | 0.080 |
Why?
| | Disaccharides | 1 | 2009 | 20 | 0.080 |
Why?
| | Genetic Loci | 1 | 2011 | 279 | 0.080 |
Why?
| | Vital Capacity | 1 | 2010 | 311 | 0.080 |
Why?
| | Insecta | 1 | 2009 | 73 | 0.070 |
Why?
| | Environmental Pollutants | 1 | 2011 | 165 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 230 | 0.070 |
Why?
| | San Francisco | 1 | 2008 | 59 | 0.070 |
Why?
| | Biopsy | 2 | 2025 | 1083 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2009 | 383 | 0.070 |
Why?
| | Isoenzymes | 1 | 2009 | 299 | 0.070 |
Why?
| | RNA | 2 | 2013 | 933 | 0.070 |
Why?
| | Catalysis | 1 | 2009 | 322 | 0.070 |
Why?
| | Primary Cell Culture | 2 | 2019 | 171 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 505 | 0.070 |
Why?
| | Odds Ratio | 3 | 2016 | 1060 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 556 | 0.070 |
Why?
| | S100 Proteins | 2 | 2018 | 36 | 0.070 |
Why?
| | Immunoglobulin E | 2 | 2025 | 323 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2026 | 2194 | 0.060 |
Why?
| | Sex Factors | 2 | 2015 | 2092 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 863 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 764 | 0.060 |
Why?
| | Monocytes | 2 | 2021 | 545 | 0.060 |
Why?
| | Keratins | 2 | 2019 | 171 | 0.060 |
Why?
| | Mucins | 2 | 2018 | 75 | 0.060 |
Why?
| | Binding Sites | 1 | 2009 | 1325 | 0.060 |
Why?
| | Airway Resistance | 1 | 2025 | 38 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1628 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3041 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2025 | 94 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2025 | 99 | 0.060 |
Why?
| | Demography | 2 | 2020 | 297 | 0.060 |
Why?
| | Virus Attachment | 1 | 2024 | 18 | 0.060 |
Why?
| | Pyrrolidines | 1 | 2025 | 116 | 0.060 |
Why?
| | Phylogeny | 1 | 2009 | 1008 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2026 | 136 | 0.050 |
Why?
| | Quinolines | 1 | 2025 | 171 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 372 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 25 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 603 | 0.050 |
Why?
| | Genetic Markers | 2 | 2018 | 345 | 0.050 |
Why?
| | Homeostasis | 2 | 2020 | 641 | 0.050 |
Why?
| | Actins | 1 | 2026 | 430 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2026 | 227 | 0.050 |
Why?
| | Axonemal Dyneins | 1 | 2022 | 9 | 0.050 |
Why?
| | Socioeconomic Factors | 3 | 2016 | 1324 | 0.050 |
Why?
| | Th1 Cells | 1 | 2023 | 140 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 125 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 223 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2019 | 3832 | 0.040 |
Why?
| | Pyrazoles | 1 | 2025 | 496 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2021 | 5 | 0.040 |
Why?
| | Alternaria | 1 | 2021 | 10 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2021 | 92 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 96 | 0.040 |
Why?
| | Respiratory System | 1 | 2022 | 156 | 0.040 |
Why?
| | Esophageal Mucosa | 1 | 2020 | 22 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2021 | 219 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2020 | 21 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 140 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 293 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 545 | 0.040 |
Why?
| | Dominican Republic | 1 | 2019 | 26 | 0.040 |
Why?
| | Interleukin-5 | 1 | 2020 | 44 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4053 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 763 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 335 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 10 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 180 | 0.040 |
Why?
| | Water Loss, Insensible | 1 | 2019 | 4 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 242 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 58 | 0.040 |
Why?
| | Arginase | 1 | 2019 | 28 | 0.040 |
Why?
| | Eugenol | 1 | 2018 | 4 | 0.040 |
Why?
| | Acetophenones | 1 | 2018 | 13 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 85 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2019 | 172 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 1058 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 261 | 0.040 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2019 | 88 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2021 | 499 | 0.040 |
Why?
| | Genes, T-Cell Receptor | 1 | 2018 | 9 | 0.040 |
Why?
| | Genes, Immunoglobulin | 1 | 2018 | 29 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 327 | 0.030 |
Why?
| | Immunomodulation | 1 | 2019 | 102 | 0.030 |
Why?
| | Metabolomics | 1 | 2024 | 715 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1123 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 207 | 0.030 |
Why?
| | Gene Ontology | 1 | 2017 | 51 | 0.030 |
Why?
| | Smell | 1 | 2018 | 132 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 67 | 0.030 |
Why?
| | Linear Models | 2 | 2010 | 858 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 607 | 0.030 |
Why?
| | Apoptosis | 1 | 2026 | 2519 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1161 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1192 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1824 | 0.030 |
Why?
| | Geography, Medical | 1 | 2016 | 11 | 0.030 |
Why?
| | Basophils | 1 | 2016 | 53 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 498 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 488 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2199 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2016 | 83 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2015 | 37 | 0.030 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2015 | 58 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1506 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3380 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 40 | 0.030 |
Why?
| | Morbidity | 1 | 2016 | 321 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2020 | 899 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2107 | 0.030 |
Why?
| | Organ Specificity | 1 | 2015 | 311 | 0.030 |
Why?
| | Exome | 1 | 2015 | 240 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 9 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.030 |
Why?
| | Immunization | 1 | 2016 | 404 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 73 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 526 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 100 | 0.020 |
Why?
| | Nuclear Pore | 1 | 2012 | 17 | 0.020 |
Why?
| | Pneumonia | 1 | 2019 | 647 | 0.020 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2013 | 135 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 201 | 0.020 |
Why?
| | Th17 Cells | 1 | 2013 | 109 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3328 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 790 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 232 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 474 | 0.020 |
Why?
| | Cell Lineage | 1 | 2013 | 368 | 0.020 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 23 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2018 | 911 | 0.020 |
Why?
| | Bacteria | 1 | 2018 | 888 | 0.020 |
Why?
| | Microbiota | 1 | 2019 | 759 | 0.020 |
Why?
| | Risk | 1 | 2013 | 906 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3611 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1332 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1813 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2011 | 199 | 0.020 |
Why?
| | Receptors, Interleukin-6 | 1 | 2009 | 46 | 0.020 |
Why?
| | Suburban Population | 1 | 2008 | 18 | 0.020 |
Why?
| | Saliva | 1 | 2010 | 247 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 811 | 0.020 |
Why?
| | Michigan | 1 | 2008 | 133 | 0.020 |
Why?
| | Acculturation | 1 | 2007 | 53 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3577 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 61 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5743 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2542 | 0.010 |
Why?
| | Environment | 1 | 2007 | 343 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2852 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2009 | 781 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4152 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8072 | 0.010 |
Why?
| | Pregnancy | 1 | 2008 | 7153 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 16741 | 0.010 |
Why?
|
|
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|